NCT04268316

Virtual Reality Behavioral Activation: An Intervention for Major Depressive Disorder

• Status: Completed
• Phase: N/A
• Study type: Interventional
• Enrollment: 20 (actual)
• Sponsor: Stanford University · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The primary purpose of this study is to test the safety and feasibility of virtual reality (VR) technology in the use of behavioral activation (BA) as a treatment for major depressive disorder (MDD). The secondary purpose of this study is to examine whether any evidence of clinical efficacy exists for VR delivered BA.

Detailed description

This is a treatment development trial. Participants will be randomly assigned to BA in VR, BA in real-life, or a waitlist control group. The former two groups will follow a BA protocol developed for primary care settings over a four-week treatment period. This study is taking place over Zoom, due to COVID-19.

Conditions

• Major Depressive Disorder
• MDD
• Depression

Interventions

Type	Name	Description
DEVICE	Virtual Reality Behavioral Activation	Participants will choose four "activities" to complete in virtual reality over the course of the week. These activities are video 360 and range from viewing animals, to viewing nature scenes, to traveling to a different location in the world, to viewing adrenaline-pumping activities.
BEHAVIORAL	Behavioral Activation in real-life	Participants will choose four pleasurable and/or mastery activities to complete over the course of the week in real life.

Timeline

• Start date: 2020-05-18
• Primary completion: 2021-01-15
• Completion: 2021-01-15
• First posted: 2020-02-13
• Last updated: 2021-06-02
• Results posted: 2021-05-10

Locations

1 site across 1 country: United States

Regulatory

• FDA-regulated device study